Efficacy and safety of regimens for drug-resistant tuberculosis

被引：1
|
作者：
Yates, Tom A. [1 ]
Nunn, Andrew J. [2 ]
机构：
[1] UCL, Inst Global Hlth, London WC1N 1EH, England
[2] UCL, MRC, Clin Trials Unit, Inst Clin Trials & Methodol, London, England
来源：
LANCET INFECTIOUS DISEASES | 2016年 / 16卷 / 11期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/S1473-3099(16)30390-5
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1218 / 1219
页数：2
相关论文
共 50 条
  • [1] Regimens for Drug-Resistant Tuberculosis
    Lange, Christoph
    Kohler, Niklas
    Gunther, Gunar
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (02): : 190 - 190
  • [2] Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children
    Jain, Lovely
    Malik, Meenakshi
    Kaur, Kulbir
    Dogra, Sarita
    Purohit, Abhishek
    Sachdeva, Meenakshi
    Chaudhry, Monica
    Pradhan, Pranita
    Mathew, Joseph L.
    [J]. CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2024, 27
  • [3] Efficacy and Safety of Linezolid in the Treatment of Extensively Drug-Resistant Tuberculosis
    Tang, Shen-Jie
    Zhang, Qing
    Zeng, Lin-Hai
    Sun, Hua
    Gu, Jin
    Hao, Xiao-Hui
    Liu, Yi-Dian
    Yao, Lan
    Xiao, He-Ping
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2011, 64 (06) : 509 - 512
  • [4] Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine
    Wallis, Robert S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (05) : 1526 - 1527
  • [5] Efficacy and safety of bedaquiline containing regimens in patients of drug-resistant tuberculosis: An updated systematic review and meta-analysis
    Rehman, Obaid Ur
    Fatima, Eeshal
    Ali, Abraish
    Akram, Umar
    Nashwan, Abdulqadir
    Yunus, Faryal
    [J]. JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2024, 34
  • [6] Drug-resistant tuberculosis: Progress towards shorter and safer regimens
    Saravu, Kavitha
    Pai, Madhukar
    [J]. LUNG INDIA, 2019, 36 (05) : 373 - 375
  • [7] Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis
    Conradie, Francesca
    Bagdasaryan, Tatevik R. R.
    Borisov, Sergey
    Howell, Pauline
    Mikiashvili, Lali
    Ngubane, Nosipho
    Samoilova, Anastasia
    Skornykova, Sergey
    Tudor, Elena
    Variava, Ebrahim
    Yablonskiy, Petr
    Everitt, Daniel
    Wills, Genevieve H. H.
    Sun, Eugene
    Olugbosi, Morounfolu
    Egizi, Erica
    Li, Mengchun
    Holsta, Alda
    Timm, Juliano
    Bateson, Anna
    Crook, Angela M. M.
    Fabiane, Stella M. M.
    Hunt, Robert
    McHugh, Timothy D. D.
    Tweed, Conor D. D.
    Foraida, Salah
    Mendel, Carl M. M.
    Spigelman, Melvin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (09): : 810 - 823
  • [8] The pipeline of new molecules and regimens against drug-resistant tuberculosis
    Black, Todd A.
    Buchwald, Ulrike K.
    [J]. JOURNAL OF CLINICAL TUBERCULOSIS AND OTHER MYCOBACTERIAL DISEASES, 2021, 25
  • [9] EFFICACY AND SAFETY OF TOPIRAMATE IN DRUG-RESISTANT EPILEPSIES
    LUEF, G
    BAUER, G
    [J]. EPILEPSIA, 1995, 36 : S151 - S151
  • [10] Systematic review and meta-analysis of the efficacy and safety of therapy with linezolid containing regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis
    Zhang, Xin
    Falagas, Matthew E.
    Vardakas, Konstantinos Z.
    Wang, Rui
    Qin, Rong
    Wang, Jin
    Liu, Youning
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (04) : 603 - 615
12345